Buscar

Rainbow lights illuminate Renown’s iconic “LOVE” sculpture, and powerful employee stories shared during Pride Month. Reno, Nev. (16 de junio de 2020) – Para celebrar el Mes del Orgullo y las comunidades LGBTQ+ de Reno, la escultura “LOVE” de Renown, una obra de arte de una tonelada de aluminio soldado con letras de 10 pies de alto y 8 pies de ancho, se iluminará con luces LED de los colores del arcoíris durante el mes de junio. La escultura “LOVE” se encuentra en la entrada principal del Renown Regional Medical Center, en Mill Street en 1155 Mill Street in Reno, Nevada, y es visible para los vehículos y peatones a lo largo de los corredores de Mill Street y Ryland Street. Dr. Tony Slonim, president and CEO of Renown says, “At Renown, we are proud to support our LGBTQ+ communities. During Pride Month and beyond, we are honored to offer an inclusive, safe environment for our staff and patients—one that celebrates diversity in all its forms. La escultura “LOVE” ya ha traído una luz resplandeciente a nuestro mundo, y estoy deseando ver la alegría que traerá a todos los que la vean con los colores del arcoíris”. Para conmemorar el Mes del Orgullo, Renown se ha comprometido a destacar a algunas de las personas LGBTQ+ que son parte de sus 7,000 empleados. Sean Savoy, director de Atención Espiritual de Renown, comparte cómo sus experiencias como hombre gay afectan positivamente a su carrera en sanación espiritual y a la compasión que muestra a los demás. “La base de la atención espiritual es la compasión: acompañar a las personas necesitadas al prestarles atención, darles apoyo y demostrarles empatía, y promover un sentido de bienestar”, afirmó Savoy. Ser miembro de la comunidad LGBTQ+ aporta ese profundo sentido de compasión y empatía de una manera muy especial y única. He descubierto que la convergencia de mi yo gay y mi yo espiritual ha sido una bendición en mi vida”. La escultura “LOVE”, creada por la artista Laura Kimpton y fabricada por Jeff Schomberg, apareció por primera vez en Burning Man, en 2019. Gracias a una asociación con la organización sin fines de lucro Artown, la escultura se inauguró en Renown en abril de 2020 y, desde entonces, ha servido como símbolo de esperanza y determinación para el personal del hospital, los pacientes y los miembros de la comunidad durante la pandemia de COVID-19. Generosos donantes y la Renown Health Foundation financiaron la instalación de la escultura.   ###   About Renown Health  Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org. Media Contact: Public Relations M: 775-691-7308 E: news@renown.org

Leer más About Renown celebra el Mes del Orgullo y las comunidades LGBTQ+ con amor

Funds used to support those addressing demographic diversity and Social Determinants of Health to improve the health of our community. Renown Health, en consonancia con su misión, visión y valores y con su compromiso de larga data de abordar los determinantes sociales de la salud, ha anunciado hoy que pondrá a disposición hasta $20,000 durante el año fiscal 2020 para financiar proyectos y organizaciones cuyo objetivo sea aumentar la presencia y la participación de las mujeres, las minorías raciales y étnicas, las personas LBGTQ+, las personas con discapacidad, las personas de bajo nivel socioeconómico y otros grupos poco representados. Renown Health strongly prefers proposals that convincingly demonstrate their potential to improve the health and wellness of northern Nevadans. The organization wishes to express its interest in supporting programs that enhance collaboration, health literacy and communication, and enhance cultural competency. “Improving the health of our community is the foundation of our work. Our mission, vision and values are the essence of what makes us Renown. We are committed to fostering an environment of diversity, inclusion and cultural competence where all are appreciated, fully engaged and motivated to make a genuine, positive difference in the health and well-being of the people and communities we serve,” said Tony Slonim, MD, DrPH, Renown’s President & CEO. As the Kaiser Family Foundation noted in recent research: “Los investigadores descubrieron que los factores sociales, como la educación, la segregación racial, los apoyos sociales y la pobreza, representaban más de un tercio del total de muertes en los Estados Unidos en un año”. https://www.ajmc.com/contributor/sophia- bernazzani/2016/05/the-importance-of-considering-the-social-determinants-of-health# Annie Zucker, gerente de Impacto Comunitario de Renown, añade: “Los determinantes sociales de la salud tienen una gran repercusión en los resultados de salud, especialmente para las poblaciones más vulnerables. I am proud that Renown, as a not-for-profit healthcare organization, considers social determinants of health to enable more compassionate and comprehensive healthcare for the patients and families we serve.” According to the CDC, it has been well-established that poverty inhibits access to healthy foods and safe neighborhoods, and that higher levels of education influence better health. El impacto de estos factores en la salud se define en Healthy People 2020 como determinantes sociales de la salud: “Social determinants of health are conditions in the environments in which people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks.” When resources are available to overcome negative social determinants of health, they can have a significant impact on improving population health outcomes. “Through diversity, inclusiveness and cultural competence we are able to better understand and respond to the health needs of our communities. We are committed to continually cultivating an environment of cultural inclusiveness. When you have a culture that acknowledges and engages everyone, the opportunities for personal growth and organizational effectiveness are limitless,” said Hector Boirie, MBA, Chief Strategy Officer. “Renown Health provides access to care with dignity and respect for all. We recognize and respect every human being, regardless of race, creed, gender, age, handicap, national origin or ability to pay. We give competent, considerate and respectful care in a safe setting that fosters a person’s comfort and dignity and is free from all forms of abuse and harassment, including gender identity or gender expression,” says Melinda Mendoza, BSN, JD, CPC, CHC, CHPC, Chief Compliance Officer. “This is a Renown Health patient right and we are proud of our organizational commitment.” Renown Health is also an Equal Opportunity employer. All qualified applicants receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, marital status, national origin, ancestry, age, genetic information, disability, or protected veteran status. “I am so pleased to serve as Renown’s Chief Financial Officer. En los EE. UU., menos del 13 % de los puestos de director financiero están ocupados por mujeres. How proud I am to help lead an organization that focuses on attracting talent based on individual competency and kindness, rather than gender, race, religion or sexual orientation,” says Ann Beck. Renown Health prefiere enfáticamente que las propuestas sumen un total aproximado de $2,500 o menos, ya que prevé financiar a 8 organizaciones. Renown Health ha puesto a disposición esta financiación adicional para el año fiscal 2020. Normalmente, financia proyectos solo durante 6 meses, y recibe las solicitudes de renovación de la financiación en los años posteriores. Se invita a todas las organizaciones 501c3 sin fines de lucro con oficinas que sirvan a los residentes del norte de Nevada a que presenten sus propuestas antes del jueves, 25 de junio de 2020. Renown Health revisará las propuestas y tomará decisiones de financiación antes del lunes, 29 de junio de 2020. Renown Health desembolsará los fondos de las subvenciones antes del martes, 30 de junio de 2020. As non-profit hospitals, Renown must meet community benefit requirements to qualify for tax- exempt status, this includes funding programs that respond to public health needs and improve overall community health. To submit a ‘Renown supports Diversity & Inclusivity grant proposal,’ fill out the grant proposal submission form. Si tiene preguntas, comuníquese con Annie Zucker, gerente de Impacto Comunitario, por correo electrónico a azucker@renown.org.     About Renown Health Renown Health is an Equal Opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, marital status, national origin, ancestry, age, genetic information, disability, or protected veteran status. Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, Renown Children’s Hospital, Renown Rehabilitation Hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. Visite renown.org para obtener más información.

Leer más About Renown Health concede subvenciones a organizaciones del área que abordan la diversidad y la inclusión

The “LOVE” sculpture, a one-ton, welded aluminum artwork with letters 10-feet tall and eight-feet wide, will find a temporary home at Renown Regional Medical Center’s main entrance at 1155 Mill Street in Reno, Nevada. Debuting at Burning Man in 2019, the free-standing structure is wired for illumination, has weighted steel base plates for anchorage and will be visible to vehicular and pedestrian traffic along the Mill Street and Ryland Street corridors.  “The overall footprint of the sculpture is 40-feet long by 4-feet deep,” says artist Jeff Schomberg, who has collaborated with artist/designer Laura Kimpton, to create 18 letter-based sculptures— including the popular “BELIEVE” piece at Civic Center Plaza in downtown Reno and the “HOME” sculpture for the Reno Aces at Greater Nevada Field. Each letter in the “LOVE” sculpture took Schomberg three to four weeks to build, and the piece takes on an added dimension when illuminated. “The sculpture is lit from within with color changing LED lights. The combination of the LEDs and the aluminum produce(s) a unique look at night,” Schomberg states.  Artist-designer Laura Kimpton, who is dyslexic, says creating monumental word art has been a powerful form of healing and expression. “I can’t tell you how beautiful it is that people will be able to see this work of art at the hospital, contemplate it and be inspired by it,” Kimpton emphasizes. For Artown, inspiring community through the arts is paramount—especially at this moment. “Artown is extremely honored to be able to provide comfort through our partnership with Renown and this incredible work of art by Laura Kimpton and Jeff Schomberg,” says Artown Executive Director Beth Macmillan. “This piece of art and the message of love during these uncertain times, promises to help enlighten, engage and heal the spirits of patients, physicians, nurses and employees at Renown who are fighting the good fight. People passing by the hospital will be warmed and inspired by the art and this one word, LOVE! Now, more than ever, the power of art will provide something beautiful to focus on and restore our confidence.” Providing comfort is in alignment with the non-profit healthcare provider’s mission “to make a genuine difference in the health and well-being of the people and communities we serve…” and is in-step with Renown’s awareness that “during a patient’s most difficult moments, art can be a source of inspiration, comfort and strength.”  Dr. Tony Slonim, president and CEO of Renown says, “I have so much respect for artists like Laura and Jeff, and the way they connect with people through their art. Creating and installing this LOVE sculpture is an act of love they are doing for others. Caring for others and their emotions is also an art. I am inspired by the many passionate caregivers today practicing the art of medicine with patients within the walls of our hospitals, practices and homes. I know this work of art will inspire them. My appreciation goes out to all who helped bring this LOVE sculpture and bright light into our world. Art has been an inspiration to me for a long time and I hope that its beauty helps to bring inspiration and comfort to everyone who gets a chance to see it.”  Members of the media are invited to attend the inaugural lighting of the LOVE sculpture, taking place on Thursday, April 16 at 8 p.m. at the artwork’s new, temporary location at Renown. Due to social distancing, the lighting will NOT be open to the public, however, a live stream of the event will be available through Renown’s Facebook page. In an effort to shine a light on our healthcare workers, several area businesses and neighborhoods are lighting up in conjunction with the LOVE sculpture lighting. Individuals are invited to do the same by placing an enclosed candle or light outside their home.  The installation of the “LOVE” sculpture was funded by generous donors and the Renown Health Foundation. The sculpture will be on display from April 16-July 16 at Renown’s Regional Medical Center, located at 1155 Mill Street, Reno.   About Artown Artown is a non-profit organization whose mission is to strengthen Reno’s arts industry, foster its civic identity and enhance its national image, thereby creating a climate for the cultural and economic rebirth of our region. The month-long summer arts festival features approximately 500 events produced by more than 150 artists, cultural organizations and businesses in locations citywide. For more information, go to artown.org.  About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. Visite renown.org para obtener más información.

Leer más About Artown Partners with Renown to Bring "Love" Sculpture on Mill St.

Hoy, la fundación de Renown Health anunció una entrega especial por parte de Sarah Carmona Zink y la Dreams Foundation, en la que se donaron cientos de pijamas, mantas para recibir a los recién nacidos, gorritos, almohadas para amamantar y más, así como un cheque de $10,500 para la Unidad de Cuidados Intensivos Neonatales (Neonatal Intensive Care Unit, NICU) del Renown Children’s Hospital. Vea las imágenes que acompañan a esta historia aquí. En los últimos tres años, Carmona Zink y la Dreams Foundation han organizado una recaudación de fondos y de artículos para bebés con el fin de ayudar a la NICU que cuidó del hijo de Carmona Zink, Howie, durante una época difícil para la familia. “Nuestra campaña de recaudación para la NICU está inspirada en Howie, quien cumplió 4 años hace poco”, dice Carmona Zink. “Hespent about a month in Renown’s NICU because he was born withgastroschisis, a condition where his intestines formed on the outside of his body.During Howie’s stay, the NICU staff was an extension of our family and cared so deeply for all of us. Our goal through this drive has always been to give back to those who gave so much to us, as well as provide a sense of normalcy to parents with babies in the NICU.During these unprecedented times, providing comfort and relief to parents is more important than ever.” “As a pediatric intensive care physician, who is also a dad, and a new grandfather, I thank Sarah Carmona Zink, her family and the Dreams Foundation for their incredible generosity and compassion. Through the years, Sarah has done so much to support the Renown Children’s Hospital NICU team and other NICU parents- she does so with such joy and enthusiasm, and we are incredibly grateful to her for all that she does,” said Tony Slonim, MD, D.Ph., Renown’s President & CEO. A través de la campaña de donaciones de este año, Carmona Zink recopiló los siguientes artículos para la NICU de Renown: 50 almohadas para amamantar 180 gorritos de bebé tejidos a mano 532 pares de pijamas 682 mantas para recibir a los bebés 8 sacos para dormir 473 almohadillas de fragancia, que los padres colocan en su piel y luego dejan con su bebé para que pueda reconfortarse con el olor de sus padres Libros para que los hermanos lean durante las visitas Artículos generales, como biberones para almacenar la leche materna, baberos, cubremanos para bebés, calcetines de recién nacido, móviles, y fundas de almohadas para amamantar Una donación monetaria de $10,500 por parte de la Dreams Foundation El Dr. Max Coppes, médico en jefe del Renown Children’s Hospital, y Larry Duncan, administrador del Renown Children’s Hospital, añaden: “Estamos realmente bendecidos con el apoyo a los residentes más pequeños del Renown Children’s Hospital. ¡Algunos de ellos pesan menos de una libra!” Sarah and her family inspire us to remain devoted to the children we serve, knowing that the community is committed to our Children’s Hospital.” “We look forward to this donation drive every year,” said Renown NICU nurse Jessica Bakke. “The work Sarah and her team do to collect these itemsis very meaningful to all of us. We don’t always have funds to purchase extra items like clothing, blankets and nursing pillows, so everything we receive through this drive makes a differencefor our babies and their families. It is a wonderful gift to be able to offer fresh clothing and other much-needed items to help these parents.”     Greg Walaitis, Chief Development Officer for Renown says, “We are extremely grateful to Sarah and the Dreams Foundation for their generous donation to our NICU. Las donaciones como estas ayudan a garantizar que tengamos suficientes artículos a mano cuando nuestros bebés y sus familias los necesiten. Esta donación permite a los padres con bebés en nuestra NICU enfocarse únicamente en la salud de su bebé, en lugar de las necesidades materiales que puedan surgir a lo largo del camino. Es un honor ser el receptor de un acto tan asombroso de bondad por tercer año consecutivo”. Fundada en 2012, la Dreams Foundation es una organización sin fines de lucro creada para satisfacer los sueños y aspiraciones insatisfechas de personas, familias, iglesias de vecindario, agencias y organizaciones de servicio a las personas, organizaciones benéficas reconocidas, clubes de niños y niñas y programas deportivos para jóvenes en las comunidades. Para obtener más información, visite dreamsfoundationinc.com. Formas de apoyar a los milagros que se hacen realidad en Renown Children’s Hospital Llame a la fundación de Renown Health al 775-982-5545. Haga una donación en renown.org/give. Envíe un cheque por correo postal a Renown Health Foundation, 1155 Mill St., O2, Reno, NV 89502. Venmo: @RenownFoundation       About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización cuenta con un centro de urgencias, dos hospitales de cuidados agudos, un hospital para niños, un hospital de rehabilitación, un grupo médico y una red de atención de urgencia, y la compañía de seguros sin fines de lucro de propiedad local más grande de la región, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Leer más About Dreams Foundation Makes $10,500 Donation Benefiting NICU Babies

El enfoque basado en la comunidad del Healthy Nevada Project revela que hasta un 90 % de los riesgos de padecer afecciones genéticas de Nivel 1 de los CDC no se detecta cuando se usan pautas de atención clínica. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. En 2018, el Healthy Nevada Project® (el mayor estudio de salud poblacional basado en la comunidad que combina datos genéticos, clínicos, ambientales y sociales) comenzó a notificarles a los participantes del estudio que habían dado su consentimiento sobre ciertas variantes genéticas que los predisponían a padecer las afecciones genéticas de Nivel 1 de los Centros para el Control y la Prevención de Enfermedades (Centers for Disease Control and Prevention, CDC). The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Los resultados iniciales de casi 27,000 participantes del estudio mostraron que el 90 % de los portadores de las afecciones genéticas de Nivel 1 de los CDC no había sido previamente identificado en un entorno clínico. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Del grupo de 26,906 participantes del Healthy Nevada Project® que el equipo de investigación de Grzymski estudió, 358 (el 1.33 %) eran portadores de afecciones de Nivel 1 de los CDC. Sin embargo, solo el 25 % de esas personas cumplían las pautas clínicas para realizarse exámenes de detección genética. Además, más del 20 % de los portadores ya tenía un diagnóstico de enfermedad relacionada con la afección genética subyacente. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” En particular, el estudio descubrió que de los 273 participantes que eran portadores de las afecciones genéticas de Nivel 1 de los CDC y que tenían información de registros clínicos, solo 22 personas mostraron sospechas previas de tener estas afecciones genéticas subyacentes. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. El Healthy Nevada Project®, que se lanzó en 2016, ofrece pruebas genéticas gratuitas a todos los residentes de Nevada, mayores de 18 años, interesados en obtener más información sobre su salud y perfil genético. Con más de 50,000 participantes del estudio inscritos en cuatro años, el Healthy Nevada Project® se ha convertido en el estudio genético de más rápida inscripción del mundo. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Obtenga más información en www.helix.com.

Leer más About Los exámenes de detección genética poblacionales demuestran que identifican de manera eficiente un aumento en el riesgo de padecer enfermedades hereditarias

Juntos, realizarán pruebas a más de 30,000 participantes del estudio elegibles antes de 2023 para determinar el riesgo de cirrosis y enfermedades relacionadas con el hígado. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. La enfermedad de hígado graso no alcohólico (EHGNA), que incluye la EHNA, es frecuente en Nevada y está subdiagnosticada, y probablemente afecte a más de 500,000 adultos en nuestro estado. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. Hay más de 12,000 personas en la lista de espera para trasplante de hígado en los EE. UU. y esta cifra continúa aumentando debido al incremento en la prevalencia de la EHGNA. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.”  “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.”  “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. Es increíblemente gratificante poder informar hallazgos clínicos para ayudar a nuestros 50,000 participantes voluntarios del estudio y asistir a los proveedores de atención médica a ayudar a sus pacientes”. La provisión de la prueba de ELF se basa en una colaboración estratégica anunciada previamente entre el Renown IHI y Gilead en julio de 2019. Esta sociedad en curso tiene como objetivo recopilar y analizar datos de salud genéticos y electrónicos anónimos de 60,000 participantes del estudio elegibles con el fin de mejorar la comprensión de la EHGNA y la EHNA y para potencialmente orientar el desarrollo de opciones de tratamiento para estas enfermedades. Acerca de la EHGNA y la EHNA La EHGNA es una acumulación de grasa en el hígado en personas que no tienen antecedentes de abuso de alcohol. Es normal que el hígado contenga algo de grasa, pero si más del 5 por ciento del contenido hepático es grasa, se considera hígado graso (esteatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. Aproximadamente, un tercio de las personas con EHNA desarrollan cirrosis o daño hepático irreversible (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. Para obtener más información o para inscribirse, comuníquese a la casilla de correo RenownIHI@renown.org o al teléfono (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.  In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health es la red de atención médica más completa e integrada de Nevada y mantiene registros médicos electrónicos para 1.02 millones de pacientes registrados. En 2016, Renown Health y el Desert Research Institute crearon el Healthy Nevada Project (HNP), el primer estudio de salud poblacional basado en la comunidad del país. En 2017, el HNP comenzó una sociedad con Helix para aprovechar sus servicios de salud poblacional, la secuenciación Exome+™ y las herramientas de participación del consumidor. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. El HNP actualmente tiene más de 60,000 participantes. For more information, visit healthynv.org.  About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. En el año fiscal 2020, que finalizó el 30 de septiembre de 2020, Siemens Healthineers, que tiene aproximadamente 54,000 empleados en todo el mundo, generó ingresos por €14.5 mil millones y un EBIT ajustado de €2.2 mil millones. Encontrará más información disponible en www.siemens-healthineers.com.Media Contacto de Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com

Leer más About Renown Institute Expands Partnership to Offer ELF Testing